To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CHPTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
416 supporting clones for gene CHP back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DC377140 brain .a 1 to 461 1 to 461   tiling clone,   461/472
(97 %)
0 diff
(100 %id)
DC317742 amygdala .a 2 to 573 1 to 572       572/572
(100 %)
0 diff
(100 %id)
DC318114 amygdala .a 2 to 605 1 to 604       604/604
(100 %)
0 diff
(100 %id)
DC345704 tongue, tumor tissue .a 2 to 608 1 to 607       607/607
(100 %)
1 diff
(99.9 %id)
DC347840 tongue, tumor tissue .a 2 to 576 1 to 575       575/575
(100 %)
0 diff
(100 %id)
DC350312 brain .a 2 to 589 1 to 588       588/592
(99 %)
2 diff
(99.7 %id)
DC365295   .a 2 to 453 1 to 452       452/457
(98 %)
1 diff
(99.8 %id)
DC370874   .a 2 to 481 1 to 480       480/480
(100 %)
0 diff
(100 %id)
DC373250 tongue .a 2 to 571 1 to 570       570/570
(100 %)
0 diff
(100 %id)
DC377000 brain .a 2 to 461 1 to 460       460/471
(97 %)
4 diff
(99.2 %id)
BP314433 mammary gland .a 2 to 583 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP365444 lung .a 2 to 582 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DC415554 trachea .a 2 to 547 1 to 546       546/546
(100 %)
1 diff
(99.9 %id)
DC416760 trachea .a 2 to 574 1 to 573       573/573
(100 %)
1 diff
(99.9 %id)
BP372807 umbilical cord .a 2 to 582 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DC375703 brain .a 3 to 255 1 to 253       253/253
(100 %)
1 diff
(99.7 %id)
DA185650 amygdala .a 13 to 556 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
BC001646 Muscle, rhabdomyosarcoma .a 16 to 3318 740 to 4044 exact tiling clone, AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 3305/4044
(81 %)
8 diff
(99.9 %id)
BC001828 Muscle, rhabdomyosarcoma .a 16 to 3318 740 to 4044 exact AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 3305/4044
(81 %)
8 diff
(99.9 %id)
DA680271   .a 62 to 623 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA274613 corpus callosum .a 63 to 624 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA406987 thalamus .a 75 to 616 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
DA780260 brain .a 87 to 659 2 to 574   capped   573/580
(98 %)
6 diff
(99.0 %id)
DA519523 brain .a 93 to 642 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA905580   .a 93 to 650 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA260859 caudate nucleus .a 96 to 670 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
AV761136 bone marrow .a 96 to 525 1 to 430       430/443
(97 %)
5 diff
(98.9 %id)
BP314276 mammary gland .a 96 to 675 1 to 580       580/582
(99 %)
2 diff
(99.7 %id)
DA228441 brain .a 97 to 504 153 to 560   capped   408/559
(72 %)
6 diff
(99.0 %id)
BP213417 cerebrum .a 97 to 670 1 to 574       574/574
(100 %)
1 diff
(99.9 %id)
AU099710   .a 97 to 396 1 to 300       300/300
(100 %)
4 diff
(98.7 %id)
BP271733   .a 97 to 696 1 to 601       601/602
(99 %)
12 diff
(98.1 %id)
NM_007236.4   .a 97 to 3326 1 to 3230 exact RefSeq,   3230/3230
(100 %)
0 diff
(100 %id)
DA308537 hippocampus .a 98 to 653 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
DB215134 trachea .a 98 to 635 2 to 539   capped   538/538
(100 %)
1 diff
(99.9 %id)
BP272618   .a 100 to 689 1 to 590       590/592
(99 %)
9 diff
(98.5 %id)
DA493213 brain .a 101 to 655 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA495776 brain .a 101 to 676 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
DA988949 synovial membrane tissue from rheumatioidarthritis .a 101 to 665 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
BF242516 bone marrow, from acute myelogenous leukemia .a 105 to 757 1 to 653       653/887
(73 %)
15 diff
(98.4 %id)
DA150675 amygdala .a 109 to 688 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DA156190 amygdala .a 109 to 631 2 to 525   capped   524/524
(100 %)
1 diff
(99.9 %id)
DA009172 adrenal gland .a 111 to 668 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA192205 amygdala .a 112 to 682 2 to 573   capped   572/573
(99 %)
2 diff
(99.7 %id)
BP278656   .a 113 to 700 1 to 588       588/588
(100 %)
2 diff
(99.7 %id)
BP278688   .a 113 to 700 1 to 587       587/587
(100 %)
3 diff
(99.5 %id)
DA019638   .a 114 to 676 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
BU429698 lymph .a 122 to 626 1 to 505       505/505
(100 %)
5 diff
(99.1 %id)
BM458169 leiomyosarcoma, uterus .a 125 to 1033 1 to 921 K188X     921/1042
(88 %)
22 diff
(97.9 %id)
DA183915 amygdala .a 127 to 671 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
DA183941 amygdala .a 127 to 625 2 to 501   capped   500/500
(100 %)
2 diff
(99.6 %id)
DA268850 caudate nucleus .a 127 to 693 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DB003856 breast, tumor tissue .a 127 to 672 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DB220136 trachea .a 127 to 674 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
DB230755 trachea .a 127 to 645 2 to 520   capped   519/519
(100 %)
0 diff
(100 %id)
BQ676378 melanotic melanoma, cell line, skin .a 128 to 900 1 to 779 V179G E186X     779/881
(88 %)
12 diff
(98.7 %id)
BP314559 mammary gland .a 128 to 709 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
BP365296 lung .a 129 to 709 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
TI_154150817   .a 129 to 777 79 to 732   AAA   654/804
(81 %)
19 diff
(97.7 %id)
BP217863 caudate nucleus .a 130 to 728 1 to 599       599/599
(100 %)
2 diff
(99.7 %id)
DA851095 placenta .a 130 to 681 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
DA989608 synovial membrane tissue from rheumatioidarthritis .a 130 to 674 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
DB150308 thymus .a 130 to 580 2 to 452   capped   451/451
(100 %)
1 diff
(99.8 %id)
DA121936 cerebellum .a 131 to 658 2 to 529   capped   528/528
(100 %)
0 diff
(100 %id)
DA389021 thalamus .a 131 to 719 2 to 591   capped   590/590
(100 %)
2 diff
(99.7 %id)
DA440989 tongue, tumor tissue .a 131 to 670 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
DA441766 tongue, tumor tissue .a 131 to 689 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA406110 thalamus .a 132 to 696 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DB009863 colon, tumor tissue .a 132 to 702 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DB228582 trachea .a 132 to 690 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA799447 brain .a 133 to 670 2 to 540   capped   539/539
(100 %)
2 diff
(99.7 %id)
BP315269 mammary gland .a 133 to 715 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BP314227 mammary gland .a 135 to 716 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA803594 brain .a 136 to 702 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DA724970   .a 141 to 713 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
AU121489 mammary gland .a 142 to 920 2 to 780 V177G H195T capped   779/781
(99 %)
9 diff
(98.9 %id)
AL601668   .a 149 to 647 1 to 499       499/499
(100 %)
1 diff
(99.8 %id)
AK312582 brain .a 151 to 828 1 to 678 exact     678/678
(100 %)
0 diff
(100 %id)
DA496498 brain .a 152 to 716 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
AA532892 normal prostate, Prostate .a 154 to 587 1 to 439     Submitted on the opposite strand 439/514
(85 %)
17 diff
(96.7 %id)
DA960968 Spleen .a 154 to 706 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
CN298057 embryonic stem cells, DMSO-treated H9 cellline .a 157 to 809 1 to 653       653/653
(100 %)
5 diff
(99.3 %id)
BM832614 stomach .a 158 to 645 1 to 488       488/488
(100 %)
3 diff
(99.4 %id)
DA662271   .a 163 to 631 2 to 471   capped   470/470
(100 %)
1 diff
(99.8 %id)
BP313016 mammary gland .a 163 to 589 1 to 428       428/583
(73 %)
1 diff
(99.9 %id)
DB229633 trachea .a 163 to 738 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
U61538   .a 164 to 860 105 to 800 exact     696/800
(87 %)
7 diff
(99.2 %id)
BQ643140 lymph, lymphoma, cell line .a 166 to 775 1 to 614       614/881
(69 %)
14 diff
(98.5 %id)
BJ995860 hepatoblastoma .a 167 to 645 1 to 479       479/479
(100 %)
0 diff
(100 %id)
DA555016   .a 168 to 747 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
BP236401 coronary artery .a 168 to 755 1 to 587       587/587
(100 %)
2 diff
(99.7 %id)
BP368650 thymus .a 168 to 749 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DB254213 uterus .a 168 to 650 2 to 484   capped   483/483
(100 %)
0 diff
(100 %id)
DA012932 adrenal gland .a 169 to 722 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA164055 amygdala .a 169 to 735 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA184305 amygdala .a 169 to 720 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA574162   .a 169 to 719 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA620186   .a 169 to 763 2 to 597   capped   596/596
(100 %)
1 diff
(99.9 %id)
DA665736   .a 169 to 716 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA761076 tongue .a 169 to 691 2 to 524   capped   523/523
(100 %)
0 diff
(100 %id)
DB125856 thymus .a 169 to 722 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DB158741 thymus .a 169 to 761 2 to 594   capped   593/593
(100 %)
0 diff
(100 %id)
DB206519 trachea .a 169 to 739 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA352150 substantia nigra .a 170 to 724 2 to 557   capped   556/556
(100 %)
4 diff
(99.3 %id)
DA805377 brain .a 170 to 738 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
BP333484 salivary gland .a 171 to 652 1 to 482       482/562
(85 %)
6 diff
(99.0 %id)
DA993043 synovial membrane tissue from rheumatioidarthritis .a 172 to 742 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
BM920260 pooled pancreas and spleen .a 174 to 1207 1 to 1038 exact     1038/1039
(99 %)
27 diff
(97.5 %id)
BQ945956 leiomyosarcoma, uterus .a 174 to 1033 1 to 867 exact available from MGC,   867/877
(98 %)
9 diff
(99.0 %id)
BP221252 colon .a 180 to 761 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BP278741   .a 180 to 762 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
DA727041   .a 180 to 757 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DA838398 placenta .a 180 to 754 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DB195574 trachea .a 180 to 686 2 to 508   capped   507/507
(100 %)
0 diff
(100 %id)
DA039664 bladder .a 181 to 745 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DA458290 tongue, tumor tissue .a 181 to 739 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DB120500 thymus .a 181 to 734 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DB202407 trachea .a 184 to 763 2 to 581   capped   580/580
(100 %)
2 diff
(99.7 %id)
CV571518 cornea, eye .a 185 to 684 1 to 500       500/500
(100 %)
0 diff
(100 %id)
BF965495 Bone, osteosarcoma, cell line .a 188 to 461 1 to 275       275/521
(52 %)
1 diff
(99.9 %id)
CN298060 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 191 to 960 1 to 770 exact     770/770
(100 %)
3 diff
(99.7 %id)
CN298065 embryonic stem cells, cell lines H1, H7, andH9 .a 193 to 942 9 to 758 exact     750/758
(98 %)
6 diff
(99.3 %id)
CR613629 Placenta Cot 25-normalized .a 193 to 3284 1 to 3092 exact tiling clone,   3092/3092
(100 %)
0 diff
(100 %id)
AL550272 placenta, Placenta Cot 25-normalized .a 193 to 1271 1 to 1060 exact     1060/1066
(99 %)
23 diff
(97.9 %id)
BM787149 stomach .a 198 to 756 1 to 559       559/559
(100 %)
0 diff
(100 %id)
BP280885   .a 200 to 782 1 to 583       583/583
(100 %)
0 diff
(100 %id)
DB209087 trachea .a 200 to 684 2 to 486   capped   485/485
(100 %)
0 diff
(100 %id)
BX393440 Neuroblastoma Cot 10-normalized .a 202 to 1083 1 to 881 E13X E15X T21X G22X H25X ...     616/955
(64 %)
25 diff
(97.4 %id)
BE778777 eye, retinoblastoma .a 205 to 777 1 to 573       573/821
(69 %)
11 diff
(98.7 %id)
BQ935339 carcinoma, cell line, Prostate .a 212 to 1155 1 to 954 S190N     954/956
(99 %)
30 diff
(96.9 %id)
BE889779 leiomyosarcoma, uterus .a 215 to 893 1 to 680 L87W A88L H89I F90S R91A ...     680/826
(82 %)
5 diff
(99.4 %id)
BE886509 leiomyosarcoma, uterus .a 216 to 773 1 to 560       560/913
(61 %)
5 diff
(99.5 %id)
CR536539   .a 241 to 828 1 to 588 exact     588/588
(100 %)
0 diff
(100 %id)
CR542085   .a 241 to 825 1 to 585       585/585
(100 %)
0 diff
(100 %id)
BF898019 marrow .a 362 to 912 562 to 15     Submitted on the opposite strand 548/568
(96 %)
1 diff
(99.9 %id)
DN913752   .a 379 to 794 1 to 416       416/416
(100 %)
2 diff
(99.6 %id)
DB136028 thymus .a 386 to 936 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
BU860597 adenocarcinoma, cell line, breast .a 398 to 1245 858 to 4     Submitted on the opposite strand 855/866
(98 %)
16 diff
(98.2 %id)
BQ279204 adenocarcinoma, cell line, breast .a 406 to 1249 852 to 1     Submitted on the opposite strand 852/971
(87 %)
10 diff
(99.0 %id)
BU538092 adenocarcinoma, cell line, breast .a 420 to 1249 837 to 1     Submitted on the opposite strand 837/943
(88 %)
17 diff
(98.2 %id)
BG429638 Kidney .a 426 to 1160 1 to 742       742/743
(99 %)
31 diff
(95.9 %id)
BU956640 adenocarcinoma, cell line, breast .a 456 to 1249 802 to 1     Submitted on the opposite strand 802/909
(88 %)
13 diff
(98.6 %id)
BU557917 adenocarcinoma, cell line, breast .a 461 to 1245 791 to 4     Submitted on the opposite strand 788/880
(89 %)
12 diff
(98.7 %id)
BU857241 adenocarcinoma, cell line, breast .a 461 to 1249 792 to 1     Submitted on the opposite strand 792/937
(84 %)
7 diff
(99.3 %id)
BU557823 adenocarcinoma, cell line, breast .a 465 to 1245 788 to 4     Submitted on the opposite strand 785/894
(87 %)
18 diff
(98.0 %id)
BQ278686 adenocarcinoma, cell line, breast .a 471 to 1249 788 to 1     Submitted on the opposite strand 788/1161
(67 %)
14 diff
(98.8 %id)
EC477056 Prostate .a 477 to 582 106 to 1       106/106
(100 %)
0 diff
(100 %id)
CB158607 Liver .a 505 to 1005 501 to 1     Submitted on the opposite strand 501/501
(100 %)
0 diff
(100 %id)
DA393000 thalamus .a 543 to 1134 2 to 593   capped   592/592
(100 %)
0 diff
(100 %id)
AA486451 ovarian tumor, ovary .a 551 to 892 1 to 343       343/343
(100 %)
4 diff
(98.9 %id)
BX117003 ovarian tumor, ovary .a 552 to 1037 1 to 486       486/486
(100 %)
3 diff
(99.4 %id)
BE925798 breast_normal .a 554 to 1016 467 to 5       463/470
(98 %)
2 diff
(99.6 %id)
AW407528 lymph .a 590 to 857 14 to 281       268/281
(95 %)
6 diff
(97.9 %id)
TI_154145903   .a 590 to 1393 86 to 891       806/830
(97 %)
68 diff
(91.9 %id)
TI_154147151   .a 590 to 999 91 to 500       410/416
(98 %)
1 diff
(99.8 %id)
AW391865 stomach .a 606 to 1222 648 to 23       626/648
(96 %)
3 diff
(99.6 %id)
AI685047 pooled .a 610 to 1026 419 to 3       417/419
(99 %)
13 diff
(96.9 %id)
BM828547 Ascites, stomach .a 619 to 987 9 to 377       369/369
(100 %)
0 diff
(100 %id)
CN298067 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 648 to 1405 1 to 759       759/759
(100 %)
3 diff
(99.7 %id)
AI424807 pooled .a 649 to 1026 379 to 3       377/421
(89 %)
18 diff
(95.8 %id)
BG014142 placenta_normal .a 651 to 944 294 to 1       294/294
(100 %)
0 diff
(100 %id)
BI057171 placenta_normal .a 651 to 944 294 to 1       294/294
(100 %)
0 diff
(100 %id)
BM048638 carcinoma, cell line, Prostate .a 693 to 1422 1 to 726       726/727
(99 %)
9 diff
(98.8 %id)
AW860298 colon .a 695 to 1059 368 to 4       365/368
(99 %)
0 diff
(100 %id)
BQ944792 carcinoma, cell line, Prostate .a 696 to 1649 1 to 971       971/972
(99 %)
27 diff
(97.3 %id)
AW579076 colon .a 706 to 1208 1 to 501       501/503
(99 %)
5 diff
(99.1 %id)
BE931499 head_neck .a 713 to 1096 413 to 30       384/423
(90 %)
0 diff
(100 %id)
BE693516 breast .a 717 to 1100 12 to 389       378/397
(95 %)
10 diff
(97.5 %id)
BE834066 ovary .a 725 to 1081 358 to 1       358/358
(100 %)
1 diff
(99.8 %id)
BF929251 nervous_tumor .a 729 to 984 259 to 4     Submitted on the opposite strand 256/259
(98 %)
0 diff
(100 %id)
AW602684 breast .a 740 to 1092 7 to 359       353/359
(98 %)
10 diff
(97.3 %id)
AW382922 head_neck .a 750 to 1100 1 to 350       350/355
(98 %)
12 diff
(96.7 %id)
DA075484 cerebellum .a 766 to 1338 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
BE082714 breast .a 769 to 1345 1 to 577       577/577
(100 %)
7 diff
(98.8 %id)
AA758301   .a 773 to 1026 255 to 3       253/261
(96 %)
0 diff
(100 %id)
DB202283 trachea .a 773 to 1335 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
AW604541 colon .a 801 to 1100 6 to 306       301/311
(96 %)
10 diff
(96.8 %id)
BQ337330 marrow .a 867 to 1154 330 to 39       292/330
(88 %)
0 diff
(100 %id)
BC008373 Bladder, carcinoma .a 886 to 3325 1 to 2439   available from MGC, AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 2439/2441
(99 %)
5 diff
(99.8 %id)
AI803117 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 888 to 1028 141 to 1       141/141
(100 %)
0 diff
(100 %id)
BU538728 adenocarcinoma, cell line, breast .a 895 to 1249 356 to 1     Submitted on the opposite strand 356/814
(43 %)
2 diff
(99.8 %id)
BF027855 bladder, carcinoma, cell line .a 912 to 1548 9 to 656   available from MGC,   648/741
(87 %)
41 diff
(94.5 %id)
DN998538 bone marrow .a 950 to 1677 7 to 733       727/733
(99 %)
1 diff
(99.9 %id)
DA688564   .a 969 to 1548 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
CV571790 cornea, eye .a 991 to 1294 1 to 306       306/306
(100 %)
11 diff
(96.5 %id)
BX369969 Placenta Cot 25-normalized .a 1011 to 1870 6 to 868       863/868
(99 %)
6 diff
(99.4 %id)
CN351494 embryonic stem cells, DMSO-treated H9 cellline .a 1031 to 1386 1 to 356       356/356
(100 %)
0 diff
(100 %id)
DN913753   .a 1077 to 1509 433 to 1       433/433
(100 %)
3 diff
(99.4 %id)
BG496038 lung, mucoepidermoid carcinoma .a 1125 to 1902 1 to 762       762/763
(99 %)
39 diff
(94.9 %id)
BI026898 marrow .a 1144 to 1346 34 to 236       203/248
(81 %)
3 diff
(98.8 %id)
BI026905 marrow .a 1147 to 1340 1 to 190       190/190
(100 %)
6 diff
(96.9 %id)
AW386046 pnet .a 1163 to 1616 1 to 454       454/454
(100 %)
0 diff
(100 %id)
CV408290 denis_drash .a 1174 to 1844 1 to 679       679/691
(98 %)
35 diff
(95.0 %id)
AW834813 leiomios .a 1239 to 1810 1 to 571       571/572
(99 %)
12 diff
(98.0 %id)
DA427384 colon .a 1240 to 1753 2 to 515   capped   514/573
(89 %)
2 diff
(99.7 %id)
CN351495 embryonic stem cells, DMSO-treated H9 cellline .a 1258 to 1808 1 to 551       551/551
(100 %)
5 diff
(99.1 %id)
AU310190 neuroblastoma .a 1270 to 1847 1 to 578       578/578
(100 %)
0 diff
(100 %id)
DA165564 amygdala .a 1277 to 1853 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
AA663033   .a 1291 to 1628 1 to 338     Submitted on the opposite strand 338/338
(100 %)
0 diff
(100 %id)
DA666673   .a 1322 to 1870 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
AW993361 breast_normal .a 1368 to 1524 161 to 5     Submitted on the opposite strand 157/162
(96 %)
0 diff
(100 %id)
AW934915 denis_drash .a 1391 to 1837 466 to 18     Submitted on the opposite strand 449/466
(96 %)
0 diff
(100 %id)
AW402369 lymph .a 1404 to 1792 1 to 389       389/389
(100 %)
6 diff
(98.5 %id)
BQ213482 large cell carcinoma, lung .a 1410 to 2319 1 to 912       912/913
(99 %)
15 diff
(98.4 %id)
TI_154138727   .a 1411 to 1905 81 to 575       495/495
(100 %)
0 diff
(100 %id)
DA369055 subthalamic nucleus .a 1427 to 1945 2 to 520   capped   519/519
(100 %)
0 diff
(100 %id)
DB268817 uterus .a 1427 to 1918 2 to 493   capped   492/492
(100 %)
1 diff
(99.8 %id)
BF332357 breast .a 1456 to 1921 17 to 482       466/483
(96 %)
13 diff
(97.4 %id)
BX391712 Placenta Cot 25-normalized .a 1464 to 2370 915 to 6       910/922
(98 %)
0 diff
(100 %id)
BE143309 head_neck .a 1482 to 1850 378 to 11     Submitted on the opposite strand 368/378
(97 %)
0 diff
(100 %id)
BF766131 colon_est .a 1560 to 1835 277 to 1     Submitted on the opposite strand 277/277
(100 %)
13 diff
(95.4 %id)
BE156165 head_neck .a 1732 to 2197 1 to 465       465/465
(100 %)
14 diff
(97.0 %id)
BF746928 breast .a 1772 to 1936 165 to 2     Submitted on the opposite strand 164/168
(97 %)
0 diff
(100 %id)
CN298055 embryonic stem cells, DMSO-treated H9 cellline .a 1807 to 2269 1 to 464       464/464
(100 %)
5 diff
(99.0 %id)
BQ958903 carcinoma, cell line, Prostate .a 1937 to 2704 17 to 788       772/946
(81 %)
22 diff
(97.7 %id)
BQ951219 large cell carcinoma, lung .a 1952 to 2469 25 to 543       519/1021
(50 %)
17 diff
(98.4 %id)
CN298063 embryonic stem cells, cell lines H1, H7, andH9 .a 1962 to 2487 1 to 526       526/526
(100 %)
0 diff
(100 %id)
BE566072 bladder, carcinoma, cell line .a 1993 to 2673 1 to 669       669/804
(83 %)
29 diff
(96.4 %id)
BE541237 cervix .a 2000 to 2646 1 to 645       645/645
(100 %)
14 diff
(97.9 %id)
CB957145 Pooled-Glandular .a 2017 to 2732 1 to 730       730/746
(97 %)
25 diff
(96.7 %id)
BQ899043 melanotic melanoma, cell line, skin .a 2029 to 2718 1 to 695       695/1012
(68 %)
28 diff
(97.3 %id)
AV714931   .a 2046 to 2752 1 to 707       707/710
(99 %)
6 diff
(99.2 %id)
BE867712 adenocarcinoma, colon .a 2096 to 2818 1 to 713       713/903
(78 %)
18 diff
(98.1 %id)
CF121452 CNCAP(3)T-225 cell line, Prostate .a 2107 to 2731 8 to 630       623/630
(98 %)
5 diff
(99.3 %id)
TI_154180535   .a 2107 to 2852 77 to 811       735/907
(81 %)
13 diff
(98.6 %id)
AA330772 embryo .a 2140 to 2419 1 to 280       280/280
(100 %)
2 diff
(99.3 %id)
H12383 placenta .a 2140 to 2673 1 to 542       542/550
(98 %)
24 diff
(95.7 %id)
CN298058 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2143 to 2838 1 to 696       696/696
(100 %)
0 diff
(100 %id)
BM894382 insulinoma, Pancreas .a 2157 to 2703 1 to 547       547/547
(100 %)
4 diff
(99.3 %id)
AA370455 Prostate .a 2177 to 2447 1 to 271       271/271
(100 %)
0 diff
(100 %id)
BI252212 hepatocellular carcinoma, cell line, Liver .a 2202 to 2743 1 to 546   fully sequenced,   546/546
(100 %)
2 diff
(99.7 %id)
BQ646446 hepatocellular carcinoma, cell line, Liver .a 2204 to 3120 1 to 927       927/929
(99 %)
22 diff
(97.7 %id)
AA345064 gall bladder .a 2216 to 2551 1 to 337       337/346
(97 %)
4 diff
(98.9 %id)
BU943000 mixed (pool of 40 RNAs) .a 2218 to 2942 1 to 726       726/793
(91 %)
12 diff
(98.5 %id)
BG677403 skin, squamous cell carcinoma .a 2221 to 2914 1 to 693       693/693
(100 %)
2 diff
(99.8 %id)
AL574189 placenta, Placenta Cot 25-normalized .a 2235 to 3281 1040 to 4       1037/1053
(98 %)
0 diff
(100 %id)
CN298059 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2239 to 2894 1 to 656       656/656
(100 %)
3 diff
(99.6 %id)
BU602700 mixed (pool of 40 RNAs) .a 2250 to 2983 1 to 738       738/742
(99 %)
7 diff
(99.1 %id)
AV712063   .a 2252 to 3011 1 to 758       758/758
(100 %)
3 diff
(99.7 %id)
CB128619 Liver .a 2282 to 2927 1 to 646       646/646
(100 %)
0 diff
(100 %id)
BG677797 skin, squamous cell carcinoma .a 2289 to 2842 1 to 554       554/554
(100 %)
0 diff
(100 %id)
H51061 liver and spleen .a 2315 to 2632 1 to 320       320/320
(100 %)
2 diff
(99.4 %id)
N74747 liver and spleen .a 2315 to 2748 1 to 440       440/445
(98 %)
10 diff
(97.8 %id)
BM468456 leiomyosarcoma, uterus .a 2333 to 3174 1 to 850       850/1011
(84 %)
27 diff
(97.4 %id)
BM769263 stomach .a 2344 to 2985 1 to 641       641/641
(100 %)
1 diff
(99.9 %id)
BQ083695 stomach .a 2344 to 2775 1 to 433       433/433
(100 %)
4 diff
(99.1 %id)
BM818778 stomach .a 2344 to 2899 1 to 556       556/556
(100 %)
0 diff
(100 %id)
BM831090 stomach .a 2344 to 2898 1 to 555       555/555
(100 %)
0 diff
(100 %id)
BM831094 stomach .a 2344 to 2978 1 to 635       635/635
(100 %)
0 diff
(100 %id)
BM830764 stomach .a 2344 to 2897 1 to 554       554/554
(100 %)
0 diff
(100 %id)
CB154253 Liver .a 2391 to 3012 1 to 621       621/621
(100 %)
2 diff
(99.7 %id)
AV695363 hepatocellular carcinoma .a 2396 to 2742 21 to 360       340/369
(92 %)
6 diff
(98.4 %id)
BE566772 bladder, carcinoma, cell line .a 2398 to 3006 1 to 626       626/767
(81 %)
38 diff
(95.1 %id)
AV684290 hepatocellular carcinoma .a 2401 to 2742 1 to 335       335/341
(98 %)
7 diff
(98.0 %id)
AV685253 hepatocellular carcinoma .a 2401 to 2740 1 to 333       333/341
(97 %)
16 diff
(95.4 %id)
AV684813 hepatocellular carcinoma .a 2401 to 2742 13 to 347       335/353
(94 %)
4 diff
(98.9 %id)
AV685926 hepatocellular carcinoma .a 2401 to 2742 1 to 335       335/341
(98 %)
4 diff
(98.9 %id)
N73354 liver and spleen .a 2401 to 2843 1 to 451     Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 451/451
(100 %)
12 diff
(97.4 %id)
BF337972 brain, glioblastoma with EGFR amplification .a 2408 to 3094 10 to 706       697/907
(76 %)
35 diff
(96.2 %id)
BU600673 mixed (pool of 40 RNAs) .a 2414 to 2918 1 to 507       507/878
(57 %)
11 diff
(98.8 %id)
AA380849   .a 2425 to 2788 1 to 366       366/366
(100 %)
8 diff
(97.9 %id)
TI_154090853   .a 2432 to 3322 984 to 93   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 892/892
(100 %)
18 diff
(98.0 %id)
TI_154057793   .a 2466 to 3322 943 to 101   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 843/911
(92 %)
26 diff
(97.2 %id)
BM798159 Ascites, stomach .a 2472 to 3017 1 to 546       546/546
(100 %)
2 diff
(99.7 %id)
AA402259 ovarian tumor, ovary .a 2482 to 3021 1 to 540       540/540
(100 %)
2 diff
(99.7 %id)
BQ221230 large cell carcinoma, lung .a 2490 to 3129 7 to 646       640/958
(66 %)
6 diff
(99.4 %id)
CN298054 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2503 to 3189 1 to 687       687/687
(100 %)
0 diff
(100 %id)
TI_154057781   .a 2513 to 3322 911 to 112   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 800/897
(89 %)
13 diff
(98.6 %id)
TI_154130870   .a 2524 to 3322 898 to 111   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 788/950
(82 %)
24 diff
(97.5 %id)
BE615097 adenocarcinoma, Pancreas .a 2563 to 3170 98 to 705       608/705
(86 %)
6 diff
(99.2 %id)
BE616436 adenocarcinoma, Pancreas .a 2563 to 3291 128 to 870       743/870
(85 %)
6 diff
(99.4 %id)
BE170204 head_neck .a 2567 to 2778 1 to 212       212/212
(100 %)
1 diff
(99.6 %id)
AV704310 adrenal gland .a 2569 to 3236 1 to 668   AAA   668/761
(87 %)
18 diff
(97.7 %id)
AW080390 esophagus, squamous cell carcinoma .a 2575 to 2987 412 to 1       412/412
(100 %)
2 diff
(99.6 %id)
TI_149275574   .a 2577 to 3322 859 to 113   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 747/968
(77 %)
34 diff
(96.5 %id)
BG436704 large cell carcinoma, lung .a 2581 to 3071 1 to 496       496/549
(90 %)
11 diff
(98.0 %id)
H83364 melanocyte .a 2588 to 3054 1 to 479       479/479
(100 %)
16 diff
(96.7 %id)
N40233 melanocyte .a 2592 to 3093 1 to 503       503/505
(99 %)
4 diff
(99.3 %id)
BQ216136 melanotic melanoma, skin .a 2592 to 3042 1 to 459       459/997
(46 %)
11 diff
(98.9 %id)
CN298061 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2593 to 3220 1 to 628       628/628
(100 %)
1 diff
(99.9 %id)
CN298066 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2603 to 2750 1 to 148       148/148
(100 %)
1 diff
(99.4 %id)
BE250526 muscle, rhabdomyosarcoma .a 2610 to 3326 34 to 748       715/899
(79 %)
5 diff
(99.5 %id)
CA425171 Bone, Subchondral Bone .a 2616 to 3322 725 to 19   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 707/710
(99 %)
0 diff
(100 %id)
BQ233152 epithelioid carcinoma, Pancreas .a 2621 to 3322 1 to 702   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 702/702
(100 %)
0 diff
(100 %id)
CA434189 lung, Metastatic Chondrosarcoma .a 2625 to 3322 714 to 15   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 700/700
(100 %)
2 diff
(99.8 %id)
BG289028 bladder, transitional cell papilloma, cell line .a 2626 to 3322 1 to 691   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 691/691
(100 %)
11 diff
(98.5 %id)
BU630889 cell lines, Chondrosarcoma .a 2626 to 3322 716 to 19   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 698/698
(100 %)
3 diff
(99.6 %id)
BE293971 muscle, rhabdomyosarcoma .a 2631 to 3264 1 to 632       632/632
(100 %)
5 diff
(99.3 %id)
BQ774880 Bone, Human Chondrosarcoma Cell Line .a 2631 to 3322 706 to 15   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 692/692
(100 %)
2 diff
(99.8 %id)
BU626339 Bone, Subchondral Bone .a 2636 to 3322 706 to 19   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 688/688
(100 %)
2 diff
(99.8 %id)
TI_149312210   .a 2640 to 3322 775 to 92   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 684/958
(71 %)
2 diff
(99.8 %id)
BU689550 lung .a 2640 to 3322 698 to 15   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 684/700
(97 %)
2 diff
(99.8 %id)
AV721948 hypothalamus .a 2641 to 3318 1 to 667       667/667
(100 %)
9 diff
(98.7 %id)
CA439631 lung, Lung Focal Fibrosis .a 2650 to 3322 693 to 19   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 675/675
(100 %)
2 diff
(99.8 %id)
AA055306 heart .a 2654 to 2908 1 to 258   fully sequenced, Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 258/258
(100 %)
4 diff
(98.5 %id)
BE789814 large cell carcinoma, lung .a 2659 to 3296 1 to 633       633/633
(100 %)
6 diff
(99.1 %id)
DW416034 Liver .a 2660 to 2953 17 to 310       294/310
(94 %)
6 diff
(98.1 %id)
AW382626 head_neck .a 2661 to 2844 7 to 190       184/190
(96 %)
4 diff
(97.9 %id)
CA419382 Bone, Human Chondrosarcoma Cell Line .a 2661 to 3322 676 to 15   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 662/662
(100 %)
0 diff
(100 %id)
BU631773 cell lines, Chondrosarcoma .a 2663 to 3322 674 to 15   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 660/660
(100 %)
0 diff
(100 %id)
CA419390 Bone, Human Chondrosarcoma Cell Line .a 2664 to 3322 675 to 15   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 661/661
(100 %)
3 diff
(99.6 %id)
BI496981 cochlea, ear .a 2675 to 3268 1 to 594       594/594
(100 %)
5 diff
(99.2 %id)
BQ436363 epithelioid carcinoma, Pancreas .a 2677 to 3322 1 to 646       646/650
(99 %)
1 diff
(99.9 %id)
N27508 melanocyte .a 2712 to 3168 1 to 467       467/506
(92 %)
10 diff
(98.1 %id)
BI253042 hepatocellular carcinoma, cell line, Liver .a 2713 to 3244 535 to 1   fully sequenced,   535/535
(100 %)
2 diff
(99.7 %id)
CA430771 cell lines, Enchondroma .a 2729 to 3322 609 to 15   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 595/595
(100 %)
2 diff
(99.7 %id)
CK824095 insulinoma, Pancreas .a 2730 to 3322 617 to 25   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 593/593
(100 %)
0 diff
(100 %id)
BY795384 eye .a 2740 to 3249 1 to 509       509/509
(100 %)
1 diff
(99.9 %id)
AW382623 head_neck .a 2741 to 2979 1 to 240       240/248
(96 %)
5 diff
(98.0 %id)
AW382638 head_neck .a 2741 to 2979 1 to 240       240/248
(96 %)
4 diff
(98.4 %id)
AI571830 anaplastic oligodendroglioma, brain .a 2742 to 3322 588 to 11   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 578/582
(99 %)
9 diff
(98.5 %id)
CA417914 Bone, Human Chondrosarcoma Cell Line .a 2742 to 3322 595 to 15   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 581/581
(100 %)
0 diff
(100 %id)
BQ327899 kidney_tumor .a 2751 to 3258 36 to 548       513/548
(93 %)
6 diff
(99.0 %id)
CA420049 Bone, Human Chondrosarcoma Cell Line .a 2751 to 3322 586 to 15   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 572/572
(100 %)
10 diff
(98.3 %id)
BQ775708 Bone, Human Chondrosarcoma Cell Line .a 2752 to 3322 586 to 15   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 572/572
(100 %)
1 diff
(99.9 %id)
AU310191 neuroblastoma .a 2771 to 3325 555 to 1       555/555
(100 %)
0 diff
(100 %id)
BF939495 brain, glioblastoma (pooled) .a 2779 to 3318 540 to 1       540/549
(98 %)
0 diff
(100 %id)
BF196886 pooled .a 2784 to 3326 544 to 2       543/544
(99 %)
0 diff
(100 %id)
AI990982 colon, colonic mucosa from 3 patients with Crohn'sdisease .a 2785 to 3322 538 to 1       538/538
(100 %)
1 diff
(99.9 %id)
AA668790 germinal center B cell .a 2789 to 3325 551 to 15       537/551
(97 %)
0 diff
(100 %id)
AA468963   .a 2790 to 3140 24 to 375       352/379
(92 %)
7 diff
(98.2 %id)
AA579613 colon, colon tumor RER+ .a 2791 to 3322 551 to 20   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 532/532
(100 %)
0 diff
(100 %id)
DB383008   .a 2792 to 3323 532 to 2       531/543
(97 %)
0 diff
(100 %id)
AW391905 stomach .a 2797 to 3044 27 to 277       251/277
(90 %)
6 diff
(97.9 %id)
BF591561 brain, glioblastoma (pooled) .a 2803 to 3318 516 to 1       516/516
(100 %)
0 diff
(100 %id)
BM894106 insulinoma, Pancreas .a 2805 to 3329 541 to 17       525/541
(97 %)
0 diff
(100 %id)
BM968768 lung, Primary Lung Epithelial Cells .a 2813 to 3322 524 to 15   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 510/510
(100 %)
5 diff
(99.1 %id)
TI_154012329   .a 2823 to 3329 624 to 118       507/625
(81 %)
0 diff
(100 %id)
BF438721 brain, glioblastoma (pooled) .a 2826 to 3318 493 to 1       493/493
(100 %)
0 diff
(100 %id)
AI144392 heart .a 2827 to 3323 497 to 1       497/497
(100 %)
0 diff
(100 %id)
AI809189 pooled .a 2827 to 3322 509 to 14   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 496/496
(100 %)
4 diff
(99.2 %id)
AI423359 brain, glioblastoma (pooled) .a 2828 to 3318 491 to 1       491/491
(100 %)
0 diff
(100 %id)
AI707495 colon .a 2828 to 3318 491 to 1       491/491
(100 %)
2 diff
(99.6 %id)
BF739769 brain, oligodendroglioma .a 2828 to 3325 498 to 1       498/498
(100 %)
2 diff
(99.6 %id)
AW410232 muscle, rhabdomyosarcoma .a 2841 to 3322 500 to 19   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 482/482
(100 %)
0 diff
(100 %id)
BE855784 brain, glioblastoma (pooled) .a 2846 to 3318 473 to 1       473/473
(100 %)
0 diff
(100 %id)
CA436126 lung, Metastatic Chondrosarcoma .a 2853 to 3329 488 to 12       477/488
(97 %)
0 diff
(100 %id)
N52503 liver and spleen .a 2858 to 3326 471 to 1       471/473
(99 %)
3 diff
(99.4 %id)
AA883758 pooled .a 2867 to 3329 464 to 3       462/464
(99 %)
0 diff
(100 %id)
AW392767 stomach .a 2873 to 3235 23 to 384       362/385
(94 %)
4 diff
(99.0 %id)
AA055215 heart .a 2887 to 3322 451 to 14   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 438/438
(100 %)
3 diff
(99.4 %id)
N94367 senescent fibroblast .a 2893 to 3322 441 to 11   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 431/431
(100 %)
1 diff
(99.8 %id)
N30527 melanocyte .a 2897 to 3173 1 to 281       281/281
(100 %)
4 diff
(98.6 %id)
AA563662 colon .a 2899 to 3323 425 to 1       425/425
(100 %)
3 diff
(99.3 %id)
AI221298 pooled .a 2905 to 3326 423 to 2       422/423
(99 %)
0 diff
(100 %id)
AI023931 parathyroid gland, parathyroid tumor .a 2906 to 3322 429 to 13   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 417/417
(100 %)
0 diff
(100 %id)
AI744624 pooled .a 2910 to 3318 423 to 15   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 409/409
(100 %)
1 diff
(99.8 %id)
AI218401 pooled .a 2911 to 3329 436 to 18       419/436
(96 %)
0 diff
(100 %id)
AI452711 pooled .a 2919 to 3326 409 to 2       408/409
(99 %)
0 diff
(100 %id)
BG996046 head_neck .a 2920 to 3069 16 to 164       149/175
(85 %)
2 diff
(98.9 %id)
R79226 placenta .a 2921 to 3312 399 to 1       399/404
(98 %)
10 diff
(97.6 %id)
BG110254 Bone, osteosarcoma, cell line .a 2928 to 3322 1 to 396   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 396/396
(100 %)
4 diff
(99.0 %id)
AA470473 colon .a 2933 to 3323 391 to 1       391/391
(100 %)
2 diff
(99.5 %id)
AA622643 germ cell tumor .a 2941 to 3322 402 to 21   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 382/382
(100 %)
0 diff
(100 %id)
AI360730 brain, glioblastoma (pooled) .a 2941 to 3322 409 to 28   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 382/382
(100 %)
2 diff
(99.5 %id)
AW195955 adenocarcinoma, Pancreas .a 2941 to 3329 396 to 8       389/396
(98 %)
0 diff
(100 %id)
AW889291 nervous_tumor .a 2949 to 3237 1 to 287       287/287
(100 %)
8 diff
(97.3 %id)
AI218127 pooled .a 2951 to 3326 376 to 1       376/376
(100 %)
1 diff
(99.8 %id)
BG913525 anaplastic oligodendroglioma with 1p/19qloss, brain .a 2953 to 3329 11 to 396       386/417
(92 %)
16 diff
(96.2 %id)
BQ185737 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 2953 to 3329 9 to 386       378/411
(91 %)
5 diff
(98.8 %id)
AA906005 pooled .a 2968 to 3322 372 to 18   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 355/355
(100 %)
0 diff
(100 %id)
AW020252 cochlea, ear .a 2978 to 3283 47 to 352       306/352
(86 %)
6 diff
(98.3 %id)
H89523 cochlea, ear .a 2979 to 3282 1 to 304       304/359
(84 %)
1 diff
(99.8 %id)
AA748160 germinal center B cell .a 2981 to 3322 366 to 25   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 342/342
(100 %)
1 diff
(99.8 %id)
AA873430 2 pooled tumors (clear cell type), Kidney .a 2981 to 3322 374 to 33   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 342/342
(100 %)
0 diff
(100 %id)
TI_149300861   .a 2986 to 3318 409 to 75   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 335/976
(34 %)
2 diff
(99.8 %id)
BM976850 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 2986 to 3318 353 to 19   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 335/343
(97 %)
2 diff
(99.5 %id)
AW664988 pooled .a 2994 to 3326 335 to 3       333/335
(99 %)
0 diff
(100 %id)
AW261963 lung, two pooled squamous cell carcinomas .a 2995 to 3329 356 to 21       336/356
(94 %)
0 diff
(100 %id)
AA970424 2 pooled tumors (clear cell type), Kidney .a 3007 to 3325 319 to 1       319/319
(100 %)
0 diff
(100 %id)
EC486248 Prostate .a 3019 to 3116 1 to 98       98/98
(100 %)
0 diff
(100 %id)
AA879079 2 pooled tumors (clear cell type), Kidney .a 3021 to 3325 305 to 1       305/305
(100 %)
0 diff
(100 %id)
BX495485 Liver .a 3030 to 3318 1 to 289   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 289/289
(100 %)
0 diff
(100 %id)
AI361357 brain, glioblastoma (pooled) .a 3030 to 3325 297 to 1       297/297
(100 %)
3 diff
(99.0 %id)
AI581622 colon .a 3031 to 3327 297 to 1       297/297
(100 %)
0 diff
(100 %id)
AW008694 brain, glioblastoma (pooled) .a 3031 to 3318 288 to 1       288/288
(100 %)
0 diff
(100 %id)
AA903275 leiomyosarcoma, soft tissue .a 3049 to 3329 282 to 2       281/282
(99 %)
0 diff
(100 %id)
EC580081 Prostate .a 3067 to 3168 1 to 102       102/102
(100 %)
0 diff
(100 %id)
EC516688 Prostate .a 3072 to 3167 11 to 105       95/105
(90 %)
6 diff
(94.3 %id)
AI187724   .a 3073 to 3325 253 to 1       253/253
(100 %)
0 diff
(100 %id)
AI626083 colon .a 3082 to 3322 255 to 15   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 241/241
(100 %)
7 diff
(97.1 %id)
AI187718   .a 3083 to 3325 243 to 1       243/243
(100 %)
0 diff
(100 %id)
H51062 liver and spleen .a 3098 to 3274 177 to 1       177/177
(100 %)
0 diff
(100 %id)
CA418017 Bone, Human Chondrosarcoma Cell Line .a 3105 to 3329 237 to 12       226/237
(95 %)
0 diff
(100 %id)
AA890505 parathyroid gland, parathyroid tumor .a 3126 to 3329 205 to 2       204/205
(99 %)
0 diff
(100 %id)
AA765447 germinal center B cell .a 3128 to 3318 219 to 29   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 191/191
(100 %)
1 diff
(99.5 %id)
AA320791 adipose tissue, white .a 3147 to 3322 1 to 176       176/176
(100 %)
0 diff
(100 %id)
AW952183   .a 3148 to 3322 1 to 175   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 175/175
(100 %)
0 diff
(100 %id)
AI266590 2 pooled tumors (clear cell type), Kidney .a 3158 to 3322 201 to 37   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 165/165
(100 %)
8 diff
(95.2 %id)
AI630099 blood .a 3170 to 3322 1 to 154   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 154/154
(100 %)
1 diff
(99.4 %id)
N53855 liver and spleen .a 3186 to 3322 148 to 12   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 137/137
(100 %)
0 diff
(100 %id)
BU588485 mixed (pool of 40 RNAs) .a 3210 to 3322 1 to 113   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 113/113
(100 %)
2 diff
(98.3 %id)
BP221603 colon .b 1 to 569 1 to 569 S6F P8S tiling clone,   569/569
(100 %)
3 diff
(99.5 %id)
AK299660 brain .c 1 to 999 2 to 1000 F82L tiling clone,   1000/1000
(100 %)
1 diff
(99.9 %id)
DC375684 brain .c 1 to 579 2 to 580 F82L     580/580
(100 %)
1 diff
(99.9 %id)
DC402207 testis .d 1 to 485 1 to 485   tiling clone,   485/485
(100 %)
1 diff
(99.8 %id)
BG398684 Kidney .d 99 to 800 1 to 732 K15N K17T K43*     662/1043
(63 %)
31 diff
(97.1 %id)
AK307060   .d 132 to 1088 1 to 957 exact tiling clone,   957/957
(100 %)
1 diff
(99.9 %id)
DC299325   .d 132 to 708 1 to 577       577/577
(100 %)
1 diff
(99.9 %id)
BQ936464 carcinoma, cell line, Prostate .d 141 to 699 1 to 572       572/1133
(50 %)
13 diff
(98.9 %id)
AK094363 cerebellum .e-u 1 to 2543 2 to 2544 exact tiling clone, available from FLJ,   2544/2544
(100 %)
14 diff
(99.5 %id)
DA063138 cerebellum .e-u 1 to 578 2 to 579 exact capped   578/578
(100 %)
1 diff
(99.9 %id)
DB297125 cerebellum .e-u 2026 to 2543 518 to 1       518/518
(100 %)
2 diff
(99.7 %id)
DA876787 Prostate .f 1 to 571 2 to 572   tiling clone, capped   571/571
(100 %)
0 diff
(100 %id)
AI075665 senescent fibroblast .f 306 to 846 544 to 6       539/583
(92 %)
10 diff
(98.3 %id)
AI023683 liver and spleen .f 378 to 846 469 to 1   tiling clone,   469/469
(100 %)
0 diff
(100 %id)
AA705060 liver and spleen .f 380 to 844 464 to 1       464/466
(99 %)
2 diff
(99.6 %id)
AA203732 liver and spleen .g 1 to 592 14 to 604 exact tiling clone, AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 591/604
(97 %)
9 diff
(98.6 %id)
DA152105 amygdala .h 1 to 574 2 to 575   tiling clone, capped   574/574
(100 %)
0 diff
(100 %id)
AK000095 colon Gene CHP, variant not shown       available from FLJ, AAA Suspected internal deletion, this clone was ignored    
BC031293 Uterus, leiomyosarcoma Gene CHP, variant not shown       available from MGC, AAA Suspected internal deletion, this clone was ignored    
CV314853 head_neck Gene CHP, variant not shown              
R05704 liver and spleen Gene CHP, variant not shown         This clone was ignored    
R05705 liver and spleen Gene CHP, variant not shown         This clone was ignored    
AA555027 breast Gene CHP, variant not shown       AAA Suspected internal deletion, this clone was ignored    
AA594430 colon, colon tumor RER+ Gene CHP, variant not shown       AAA Suspected internal deletion, suspected internal deletion, this clone was ignored    
BG742251 skin Gene CHP, variant not shown         Suspected internal deletion, this clone was ignored    
BM454868 leiomyosarcoma, uterus Gene CHP, variant not shown         This clone was ignored    
BQ717975 sympathetic trunk Gene CHP, variant not shown         Suspected internal deletion, this clone was ignored    
BC051815 Uterus, leiomyosarcoma Gene CHP, variant not shown       available from MGC, AAA This clone was ignored    
BU508108 leiomyosarcoma, uterus Gene CHP, variant not shown         Suspected internal deletion, this clone was ignored    
BP314750 mammary gland Gene CHP, variant not shown         Suspected internal deletion, this clone was ignored    
BM750350 stomach Gene CHP, variant not shown         Suspected internal deletion, this clone was ignored    
BM784216 stomach Gene CHP, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e-u, .f, .g, .h, .i-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI